- Home
- ONFO vs SYRS Comparison
ONFO vs SYRS Comparison
Compare ONFO & SYRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONFO
- SYRS
- Stock Information
- Founded
- ONFO 2018
- SYRS 2011
- Country
- ONFO United States
- SYRS United States
- Employees
- ONFO N/A
- SYRS N/A
- Industry
- ONFO Computer Software: Programming Data Processing
- SYRS Biotechnology: Pharmaceutical Preparations
- Sector
- ONFO Technology
- SYRS Health Care
- Exchange
- ONFO Nasdaq
- SYRS Nasdaq
- Market Cap
- ONFO 6.2M
- SYRS 3.6M
- IPO Year
- ONFO 2022
- SYRS 2016
- Fundamental
- Price
- ONFO $1.23
- SYRS $0.08
- Analyst Decision
- ONFO
- SYRS Hold
- Analyst Count
- ONFO 0
- SYRS 5
- Target Price
- ONFO N/A
- SYRS $3.00
- AVG Volume (30 Days)
- ONFO 22.2K
- SYRS 41.9M
- Earning Date
- ONFO 11-15-2024
- SYRS 03-26-2025
- Dividend Yield
- ONFO N/A
- SYRS N/A
- EPS Growth
- ONFO N/A
- SYRS N/A
- EPS
- ONFO N/A
- SYRS N/A
- Revenue
- ONFO $6,590,171.00
- SYRS $386,000.00
- Revenue This Year
- ONFO $133.59
- SYRS N/A
- Revenue Next Year
- ONFO N/A
- SYRS N/A
- P/E Ratio
- ONFO N/A
- SYRS N/A
- Revenue Growth
- ONFO 29.25
- SYRS N/A
- 52 Week Low
- ONFO $0.39
- SYRS $0.07
- 52 Week High
- ONFO $1.88
- SYRS $6.93
- Technical
- Relative Strength Index (RSI)
- ONFO 47.15
- SYRS 33.22
- Support Level
- ONFO $1.11
- SYRS $0.07
- Resistance Level
- ONFO $1.32
- SYRS $0.30
- Average True Range (ATR)
- ONFO 0.09
- SYRS 0.03
- MACD
- ONFO -0.01
- SYRS -0.00
- Stochastic Oscillator
- ONFO 43.64
- SYRS 4.96
About ONFO Onfolio Holdings Inc.
Onfolio Holdings Inc actively manages small online businesses that operate in sectors with long-term growth opportunities, have positive and stable cash flows, face minimal threats of technological or competitive obsolescence, and can be managed by existing teams or have management teams largely in place.
About SYRS Syros Pharmaceuticals Inc.
Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies.